Cas:1851-09-8 4-Chlorobenzenesulphonylacetonitrile manufacturer & supplier

We serve Chemical Name:4-Chlorobenzenesulphonylacetonitrile CAS:1851-09-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Chlorobenzenesulphonylacetonitrile

Chemical Name:4-Chlorobenzenesulphonylacetonitrile
CAS.NO:1851-09-8
Synonyms:2-((4-Chlorophenyl)sulfonyl)acetonitrile;4-Chlorophenyl CyanoMethyl Sulfone;4-Chlorobenzenesulphonylacetonitrile;p-CHLOROPHENYLSULFONYLACETONITRILE;[(4-Chlorophenyl)sulfonyl]acetonitrile;p-chlorophenylsulfonyl-cyanomethane;Acetonitrile, 2-[(4-chlorophenyl)sulfonyl]-;MFCD00045626;4-Chlorophenylsulfonylacetonitrile;2-[(4-chlorophenyl)sulfonyl]acetonitrile
Molecular Formula:C8H6ClNO2S
Molecular Weight:215.657
HS Code:2926909090

Physical and Chemical Properties:
Melting point:168-172 °C
Boiling point:421.3±45.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.562
PSA:66.31000
Exact Mass:214.980774
LogP:0.86

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3276
Packing Group:III


Contact us for information like 2-((4-Chlorophenyl)sulfonyl)acetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(4-chlorophenyl)sulfonyl]acetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-CHLOROPHENYLSULFONYLACETONITRILE Use and application,Acetonitrile, 2-[(4-chlorophenyl)sulfonyl]- technical grade,usp/ep/jp grade.


Related News: Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. (5-Benzyloxy-10-hydroxy-9-methyl-4-oxo-1,2,3,4-tetrahydro-anthracen-2-yl)-methylamino-acetic acid ethyl ester manufacturers A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 3,7-dichloro-2,8-dimethyl-5-phenylphenazin-5-ium chloride suppliers Case in point: Hansoh Pharma is seeking approvals for its third-generation EGFR inhibitor Ameile (almonertinib) for newly diagnosed EGFR-mutated non-small cell lung cancer. 2,2′-Oxybis[tetrafluoroethanesulfonyl fluoride] vendor & factory.